IP Library Granted Patent US 11,471,335
Granted Patent B2
US 11,471,335 · App. 16/539,192 · Granted Oct 18, 2022

Gel-within-gel wound dressing

Inventors: Ehsan Jabbarzadeh (Columbia, SC); Sara Eslambolchimoghadam (Columbia, SC)
Assignee: University of South Carolina
A61F13/0213A61F13/00068A61L15/425A61L27/52A61F13/0223A61F2013/530802A61L15/28A61L15/325A61L15/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,471,335
App. No.
16/539,192
Granted
Oct 18, 2022
Kind
B2
Abstract

Wound dressings, methods for forming the wound dressings, and methods for using the wound dressings are described. Wound dressings include a crosslinked hydrogel matrix and a plurality of porous absorbent microspheres encapsulated in the crosslinked matrix. The hydrogel matrix and the microspheres can include the same or different hydrogel polymers, e.g., alginates or the like. The wound dressings can be used in treating chronic wounds and burn wounds and can promote autolytic debridement.

Claims (27)

1. A wound dressing comprising:

a crosslinked absorbent hydrogel matrix comprising a first biocompatible polymer;

a plurality of porous absorbent microspheres encapsulated in the crosslinked absorbent hydrogel matrix, each porous absorbent microsphere comprising a crosslinked second biocompatible polymer, wherein the first biocompatible polymer and the second biocompatible polymer are the same.

2. The wound dressing of claim 1 , wherein the crosslinked absorbent hydrogel matrix and/or the porous absorbent microspheres further comprise a plasticizer.

3. The wound dressing of claim 2 , wherein the plasticizer comprises dioctylphthalate, castor oil, diacetylated monoglycerides, diethyl phthalate, glycerin, mono- and di-acetylated monoglycerides, polyethylene glycol, propylene glycol, triacetin, triethyl citrate, bis-(2-butoxyethyl) adipate, and bis-(2-ethylhexyl) sebacate polyvinyl alcohol, polyvinyl alcohol, glycerol, or polyethylene glycol.

4. The wound dressing of claim 1 , wherein the first biocompatible polymer and the second biocompatible polymer are selected from an alginate, a collagen, a gelatin, a cellulose, a poly(lactic-co-glycolic acid), a polycaprolactone, or derivatives or combinations thereof.

5. The wound dressing of claim 1 , wherein the crosslinked absorbent hydrogel matrix and/or the porous absorbent microspheres further comprise a therapeutic agent.

6. The wound dressing of claim 1 , wherein the crosslinked absorbent hydrogel matrix and/or the porous absorbent microspheres further comprise a surfactant, an electrolyte, a pH regulator, a colorant, a chloride source, or a combination thereof.

7. A method for forming a wound dressing comprising:

forming a plurality of porous absorbent microspheres, the porous absorbent microspheres comprising a crosslinked first biocompatible polymer;

forming a hydrogel precursor according to a method that includes forming a hydrogel precursor solution and removing water from the hydrogel precursor solution to form a hydrogel precursor base; and

distributing the plurality of porous absorbent microspheres within the hydrogel precursor; and

crosslinking the hydrogel precursor.

8. The method of claim 7 , wherein the method for distributing the plurality of porous absorbent microspheres within the hydrogel precursor comprises distributing the plurality of porous absorbent microspheres across a surface of the hydrogel precursor base, coving the porous absorbent microspheres with additional hydrogel precursor solution, and removing water from the additional hydrogel precursor solution.

9. The method of claim 7 , wherein the hydrogel precursor solution comprises from about 0.5% w/v to about 20% w/v of a second biocompatible polymer.

10. The method of claim 7 , wherein the hydrogel precursor solution comprises from 0 to about 20w/v % of a plasticizer.

11. The method of claim 7 , wherein the plurality of porous absorbent microspheres has been formed according to a method that includes injecting a microsphere precursor solution into a solution that includes a crosslinking agent and/or a crosslink initiator.

12. The method of claim 7 , wherein the hydrogel precursor is crosslinked through contact of the hydrogel precursor with a crosslinking agent or a crosslink initiator.

13. A method for treating a wound comprising:

applying a wound dressing to the wound, the wound dressing comprising a crosslinked absorbent hydrogel matrix comprising a first biocompatible polymer and a plurality of porous absorbent microspheres encapsulated in the crosslinked absorbent hydrogel matrix, each porous absorbent microsphere comprising a crosslinked second biocompatible polymer, wherein the first biocompatible polymer and the second biocompatible polymer are the same;

maintaining moisture at the wound with the wound dressing; and

following a period of time, removing the wound dressing from the wound, the wound dressing at removal carrying exudate from the wound.

14. The method of claim 13 , wherein the wound is a chronic wound.

15. The method of claim 13 , wherein the wound is a burn wound.

16. The method of claim 13 , wherein the method further comprises irrigating the wound, the irrigation removing debris from the wound.

17. The method of claim 16 , wherein the debris comprises liquefied necrotic tissue.

18. The method of claim 17 , wherein the method further comprises applying a fresh wound dressing to the wound and repeating the method for autolytic debridement of the wound.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 20, 2019
From: UNIVERSITY OF SOUTH CAROLINA
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 050455/0598 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2019
From: JABBARZADEH, EHSAN; ESLAMBOLCHIMOGHADAM, SARA
To: UNIVERSITY OF SOUTH CAROLINA
Reel/Frame 050306/0897 →
Continuity (2)
Provisional Application 62727232 · Sep 5, 2018
Related Publication 20200069478A1 · Mar 5, 2020